Prime Medicine, Inc. (NASDAQ: PRME)
$3.0300
-0.1200 ( -3.81% ) 37.8K
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Market Data
Open
$3.0300
Previous close
$3.1500
Volume
37.8K
Market cap
$413.16M
Day range
$3.0160 - $3.1750
52 week range
$2.5600 - $9.7700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 09, 2024 |
4 | Insider transactions | 1 | Dec 09, 2024 |
4 | Insider transactions | 1 | Dec 09, 2024 |
10-q | Quarterly Reports | 71 | Nov 12, 2024 |
8-k | 8K-related | 15 | Nov 12, 2024 |
8-k | 8K-related | 14 | Oct 24, 2024 |
4 | Insider transactions | 1 | Oct 10, 2024 |
8-k | 8K-related | 59 | Sep 30, 2024 |
8-k | 8K-related | 15 | Aug 08, 2024 |
10-q | Quarterly Reports | 64 | Aug 08, 2024 |